Alport Syndrome
- 12 July 2024
- journal article
- research article
- Published by Elsevier in Advances in Kidney Disease and Health
- Vol. 31 (3) , 170-179
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Dual inhibition of the endothelin and angiotensin receptor ameliorates renal and inner ear pathologies in Alport miceThe Journal of Pathology, 2023
- The role of lipotoxicity in kidney disease: From molecular mechanisms to therapeutic prospectsBiomedicine & Pharmacotherapy, 2023
- A Randomized, Double‐Blind, Placebo‐Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX‐02 in Healthy SubjectsClinical Pharmacology in Drug Development, 2021
- Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndromeEBioMedicine, 2021
- Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults–an update for 2020Pediatric Nephrology, 2020
- Type IV Collagen Mutations in Familial IgA NephropathyKidney International Reports, 2020
- Collagen IV Gene Mutations in Adults With Bilateral Renal Cysts and CKDKidney International Reports, 2020
- Crosstalk Between Lipids and Mitochondria in Diabetic Kidney DiseaseCurrent Diabetes Reports, 2019
- Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: An emerging paradigm in diabetic nephropathyEuropean Journal of Internal Medicine, 2014
- Renal biopsy diagnosis in children presenting with haematuriaPediatric Nephrology, 1998